Filtered By:
Drug: Proton Pump Inhibitors PPIs
Countries: Egypt Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Pharmacogenetic and clinical predictors of response to clopidogrel plus aspirin after acute coronary syndrome in Egyptians
Conclusion
These results highlight that CYP2C19*2, along with diabetes, and use of proton pump inhibitor and statin are important factors jointly associated with variability in clinical response to DAPT following ACS in Egyptians.
Source: Pharmacogenetics and Genomics - September 1, 2018 Category: Genetics & Stem Cells Tags: Original Articles Source Type: research
